Observational cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitis

Observational cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitis - RemiT-JAV

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001648

Enrollment

240

Registered

2009-02-28

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-neutrophil cytoplasmic antibody(ANCA) associated vasculitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed ANCA related vasculitis No previous treatments

Exclusion criteria

Exclusion criteria: Patients with relapse Malignancy Replicating hepatitis B and C

Design outcomes

Primary

Measure	Time frame
Time to remission	—

Secondary

Measure	Time frame
Survival Cause of death Treatment response Relapse Severe infections and risk factor Other adverse events Pathologic analysis in pulmonary limited vasculitis The concordance rates of classification	—

Countries

Japan

Contacts

Public ContactKen-ei Sada

Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Secretariat

vas-mhlw@md.okayama-u.ac.jp086-235-7235

Outcome results